Biogen Inc. (BIIB)

Biogen Revenue

Biogen had revenue of $2.80B in the quarter ending September 30, 2026, with 10.63% growth. This brings the company's total for the last twelve months to $10.30B, up 2.30% year-over-year. In the year 2025, Biogen had annual revenue of $9.89B with 2.22% growth. That makes Biogen the 1,443rd largest company in the world by revenue and 443rd in the United States.

• Revenue (ttm): $10.30B
• Revenue Growth: +2.30%
• P/S Ratio: 3.64
• Revenue / Employee: $1,372,973
• Employees: 7,500
• Market Cap: 37.49B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Multiple Sclerosis Product 4.04B 40.8%
• Other 2.77B 28.0%
• Rare Disease Product 2.15B 21.8%
• Biosimilars Product 729.10M 7.4%
• Other Product 197.20M 2.0%

By Geography

Chart

• Rest of World 3.57B 36.1%
• United States 3.55B 35.9%
• Other 2.77B 28.0%

Fiscal year ended Dec 31, 2025 See the full Biogen breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.89B	214.70M	2.22%
Dec 31, 2024	9.68B	-159.70M	-1.62%
Dec 31, 2023	9.84B	-337.80M	-3.32%
Dec 31, 2022	10.17B	-808.30M	-7.36%
Dec 31, 2021	10.98B	-2.46B	-18.32%
Dec 31, 2020	13.44B	-933.30M	-6.49%
Dec 31, 2019	14.38B	925.00M	6.88%
Dec 31, 2018	13.45B	1.18B	9.61%
Dec 31, 2017	12.27B	825.10M	7.21%
Dec 31, 2016	11.45B	685.00M	6.36%
Dec 31, 2015	10.76B	1.06B	10.93%
Dec 31, 2014	9.70B	2.77B	39.97%
Dec 31, 2013	6.93B	1.42B	25.66%
Dec 31, 2012	5.52B	467.83M	9.27%
Dec 31, 2011	5.05B	332.21M	7.04%
Dec 31, 2010	4.72B	339.08M	7.75%
Dec 31, 2009	4.38B	279.84M	6.83%
Dec 31, 2008	4.10B	925.89M	29.19%
Dec 31, 2007	3.17B	488.57M	18.21%
Dec 31, 2006	2.68B	260.55M	10.76%
Dec 31, 2005	2.42B	-	-

Data Source: Fiscal.ai Last updated: Oct 28, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error